This Fool considers how two low-risk and well-established FTSE shares could offer stability and growth during a period of ...

JPMorgan raises Intermediate Capital target to 2,763 (2,645) pence - 'overweight' Goldman Sachs cuts Barclays price target to 325 (330) pence - 'buy' HSBC raises Legal & General to 'buy' - price ...

That's where the best WhatsApp alternatives come in, offering a different messaging platform. It doesn't matter how much you disagree with recent policy changes at Meta, losing WhatsApp isn't as ...

Once complete, Pfizer's stake in Haleon will fall from 15.0% to around 7.3%. Pfizer's move comes after Haleon's spin-off as an independent consumer healthcare company, part of plans to reshape its ...

Once complete, Pfizer's stake in Haleon will fall from 15.0% to around 7.3%. Pfizer's move comes after Haleon's spin-off as an independent consumer healthcare company, part of plans to reshape its ...

Deal priced at a 2.8% discount to the prior closing level Shares of Haleon rose on Wednesday after the stake deal Pfizer Inc. sold about 700 million shares in Haleon Plc, further paring its stake in ...

Pfizer will sell shares worth £2.50 billion (€2.96 billion) in Haleon, lowering its stake in the British consumer healthcare company to about 7.3% from 15%, its bookrunner JPMorgan has said.

Pfizer has sold 700 million shares in British consumer-healthcare business Haleon for 2.50 billion pounds, equivalent to US$3.05 billion, it said in a statement. The U.S. drugmaker said Wednesday ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

NEW YORK, Jan. 14 (Xinhua) -- Pfizer Inc., the American multinational pharmaceutical and biotechnology corporation, is offering around 700 million shares in Haleon Plc, representing a roughly 7.7 ...